Prostate Cancer Treatment Stages

Success rate for treating prostate cancer will depend on the stage of the cancer and how far the cancer has spread. There is a labeling system of T-1 through T-4 which indicates how far the cancer has spread from it's original site and the size of the cancer.

Ablatherm® HIFU is an appropriate treatment option for essentially any male who has prostate cancer which can be cured by any other means. The stages of cancer of the prostate are:

stage 1 prostate cancer cure rate

T-1 Prostate cancer

This is a cancer which has no signs or symptoms and is totally unsuspected.

The prostate feels normal to the physician on rectal exam. The cancer is detected either by an elevated Prostatic Specific Antigen (PSA) blood test and subsequent biopsies or by examination of tissue removed during treatment of an enlarged prostate. This tumor can be cured by surgery, radiation, and Ablatherm® HIFU.

stage 3 prostate cancer

T-3 Prostate cancer

This is a tumor that has spread outside the prostate capsule and may have reached the seminal vesicles. This tumor is not curable by surgery, radiation, or HIFU.

stage 2 prostate cancer cure rate t-2

T-2 Prostate cancer

This is a tumor which is suspected on rectal exam.

One or both lobes of the prostate have areas of firmness and biopsies reveal the cancer. The PSA is also usually elevated.

This tumor can be cured by surgery, radiation, and Ablatherm® HIFU.


stage 4 prostate cancer

T-4 Prostate cancer

This tumor may have spread to the rectum or bladder or to distant organs or bone.

This tumor is not curable by surgery, radiation, or HIFU.

Cure Rate for Prostate Cancer

cure rate for prostate cancer - prostate cancer screening

Is My Cancer Curable by Treatment with Ablatherm® HIFU?

Prostate cancer is a slow growing disease, and early detection is key. Statistics show that the survival rate for men diagnosed with prostate cancer approaches 90% at 5 years.

Patients with both T-1 and T-2 prostate cancer may have an imaging scan, such as an MRI or CT, to try to detect cancerous extension outside the prostate or to other organs (lymph nodes, liver, etc.). A Bone Scan may be used to rule out spread to bone.

Patients with T-1 and T-2 prostate cancer who have had external beam radiation therapy (EBRT) and recurrent cancer, but no spread outside the prostate, can be treated for cure by Ablatherm® HIFU. The sooner a patient is treated after the diagnosis of failed EBRT the better the chance he has for cure by Ablatherm® HIFU.

 

More about HIFU

Detection of
Prostate Cancer

Prostate cancer is the most common form of cancer in men in the United States after skin cancer. There are generally no signs or symptoms in the early stages of prostate cancer.

The cancer occurs when cells divide at an uncontrolled, abnormal rate, creating a mass of tissue known as a tumor.

If a tumor is detected, tests must be done to determine if the tumor is benign or malignant.

Since age is a major factor, older men should be screened for early detection with a PSA test and a digital rectal exam.

A biopsy will be performed if prostate cancer is suspected.

Diagnosis of
Prostate Cancer

The biopsy will help doctors determine if the tumor is cancerous and if the cancer has spread.

If you have been diagnosed with prostate cancer , your doctor will explain your treatment options based on your examination, PSA and biopsy results. You will want to learn and understand your treatment options, including High Intensity Focused Ultrasound for organ confined prostate cancer.

Discuss the treatment options, as well as the risks and benefits of each with your physician. The best prostate cancer treatment option for you will depend on the stage of your prostate cancer along with your age, health and personal preferences.

 

 

Contact Maple Leaf HIFu

Tel: 877 370 4438